General Info

Enzo Biochem is engaged in the research, development and manufacture of health care products based on molecular biology and genetic engineering techniques. The company's proprietary labeling and detection products for gene sequencing and genetic analysis are sold to the life sciences market throughout the world. Its therapeutic division is in various stages of clinical evaluation of its proprietary gene medicine for HIV-1 infection and its proprietary immune regulation medicines for hepatitis B, hepatitis C and Crohn's Disease. It is also researching compounds aimed at producing new mineral and organic bone, including technology for the treatment of osteoporosis and fractures. Enzo also holds a patent that covers a method and materials designed to correct point mutations or small insertions or deletions of genetic material. The company owns or licenses over 200 patents worldwide. Enzo Biochem is located in Farmingdale, N.Y., and trades on the New York Stock Exchange under the symbol ENZ.